Alpha 2.0
Login Register
» Articles » PMID: 31548292

Esketamine for Treatment Resistant Depression

Overview
Journal BMJ
Specialty General Medicine
Date 2019 Sep 25
PMID 31548292
Citations 13
Authors
Sameer Jauhar
Paul Morrison
Affiliations
Soon will be listed here.
Citing Articles

Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment.

Kwasny A, Cubala W, Wlodarczyk A, Pastuszak K Pharmacol Rep. 2024; 76(6):1325-1332.

PMID: 39207673 PMC: 11582297. DOI: 10.1007/s43440-024-00641-1.

Comparison of Effects of Propofol Combined with Different Doses of Esketamine for ECT in the Treatment of Depression: A Randomized Controlled Trial Protocol.

Chen X, Zhou R, Lan L, Zhu L, Chen C, Zhang X Neuropsychiatr Dis Treat. 2024; 20:1107-1115.

PMID: 38774255 PMC: 11108059. DOI: 10.2147/NDT.S463028.

Dose-response study of propofol combined with two different doses of esketamine for laryngeal mask airway insertion in women undergoing hysteroscopy.

Lin Y, Chen S, Zheng X, Yu S, Lu L Heliyon. 2024; 10(9):e30511.

PMID: 38765139 PMC: 11101821. DOI: 10.1016/j.heliyon.2024.e30511.

Menin Reduces Parvalbumin Expression and is Required for the Anti-Depressant Function of Ketamine.

Leng L, Zhuang K, Lin H, Ding J, Yang S, Yuan Z Adv Sci (Weinh). 2023; 11(5):e2305659.

PMID: 38044302 PMC: 10837338. DOI: 10.1002/advs.202305659.

Influence of low-dose esketamine on postoperative depressive symptoms in patients with breast cancer (EASE): study protocol for a randomised controlled trial.

Wei Q, Chen C, Zhu J, Mei B, Liu X BMJ Open. 2023; 13(9):e075767.

PMID: 37748853 PMC: 10533742. DOI: 10.1136/bmjopen-2023-075767.